CR1
Showing 1 - 25 of >10,000
CX3CR1+T Cell Predict Immunotherapy Efficacy
Recruiting
- Non-small Cell Lung Cancer
- PD-1 inhibitor based immunotherapy
-
Changsha, Hunan, China
- +1 more
Sep 19, 2023
Acute Lymphoid Leukemia, Acute Lymphoblastic Leukemia Trial in Aurora (CD19 Directed CAR T Cell)
Not yet recruiting
- Acute Lymphoid Leukemia
- Acute Lymphoblastic Leukemia
- CD19 Directed CAR T Cell
-
Aurora, ColoradoUniversity of Colorado Hospital
Sep 12, 2022
Pruritus, Notalgia Paresthetica Trial in Coral Gables (difelikefalin 2.0 mg tablets, difelikefalin 1.0 mg tablets, difelikefalin
Recruiting
- Pruritus
- Notalgia Paresthetica
- difelikefalin 2.0 mg tablets
- +3 more
-
Coral Gables, FloridaCara Therapeutics Study Site
Aug 3, 2023
Periapical Diseases Trial in Van (Er,Cr:YSSG laser, Control)
Active, not recruiting
- Periapical Diseases
- Er,Cr:YSSG laser
- Control
-
Van, TurkeyYuzuncu Yıl University
Jul 28, 2022
Narcolepsy Type 1, Narcolepsy With Cataplexy Trial (NLS-2, Placebo)
Not yet recruiting
- Narcolepsy Type 1
- Narcolepsy With Cataplexy
- NLS-2
- Placebo
- (no location specified)
Jun 21, 2023
Coronary Heart Disease, Valve Disease, Heart Trial in Ottawa (Virtual Cardiac Rehabilitation Program, Case Managed Home Program)
Completed
- Coronary Heart Disease
- Valve Disease, Heart
- Virtual Cardiac Rehabilitation Program
- Case Managed Home Program
-
Ottawa, Ontario, CanadaUniversity of Ottawa Heart Institute
Aug 25, 2022
Autoimmune Inner Ear Disease Trial in New Hyde Park (Anakinra 100Mg/0.67Ml Inj Syringe (Period 1), Placebo injection (Period 1),
Recruiting
- Autoimmune Inner Ear Disease
- Anakinra 100Mg/0.67Ml Inj Syringe (Period 1)
- +3 more
-
New Hyde Park, New YorkNorthwell Health, Hearing& Speech Center
Oct 18, 2022
PreDiabetes Trial in Sohag (HbA1c, lipid profile, CBC)
Recruiting
- PreDiabetes
- HbA1c
- +8 more
-
Sohag, EgyptSohag university hospital
May 8, 2023
Mild Cognitive Impairment, MDD, Alzheimer's Dementia Trial in Toronto (Receive tDCS+CR, Facilitate tDCS + CR)
Active, not recruiting
- Mild Cognitive Impairment
- +4 more
- Receive tDCS+CR
- Facilitate tDCS + CR
-
Toronto, Ontario, CanadaCentre for Addiction and Mental Health
Jan 13, 2022
HIV Trial in Roma (Antiviral Agents)
Not yet recruiting
- HIV Infections
- Antiviral Agents
-
Roma, ItalyFondazione PoliclinicoAgostino Gemelli IRCCS
Feb 9, 2023
Atrial Fibrillation, Obesity Trial in Calgary (CR with added BWLT)
Recruiting
- Atrial Fibrillation
- Obesity
- CR with added BWLT
-
Calgary, Alberta, CanadaUniversity of Calgary
Oct 31, 2022
Refractory Metastatic Colorectal Cancer, Solid Tumor, Metastatic Microsatellite-stable Colorectal Cancer Trial in Milano
Recruiting
- Refractory Metastatic Colorectal Cancer
- +3 more
- CR6086
- AGEN2034
-
Milano, MI, ItalyIstituto Nazionale dei Tumori
Jan 24, 2022
Chronic Kidney Diseases, Pruritus Trial (Difelikefalin 1 mg Oral Tablet, Placebo Oral Tablet)
Recruiting
- Chronic Kidney Diseases
- Pruritus
- Difelikefalin 1 mg Oral Tablet
- Placebo Oral Tablet
-
Northridge, California
- +5 more
Dec 21, 2022
IL-8+ naïve T Cells as a Biomarker for Thymoma Identification
Not yet recruiting
- Thymoma
- level of IL-8+ initial T cells
- (no location specified)
Jul 23, 2022
Nasopharyngeal Carcinoma, De-escalation Therapy Trial in Guangzhou (Cisplatin-based induction chemo, Full course of PD-1/PD-L1
Recruiting
- Nasopharyngeal Carcinoma
- De-escalation Therapy
- Cisplatin-based induction chemotherapy
- +4 more
-
Guangzhou, Guangdong, ChinaSun Yat-sen University Cancer Center
Oct 16, 2023
Schizophrenia, Schizophrenia Spectrum Disorder, Schizophrenia and Related Disorders Trial in Whitby (Transcranial direct current
Recruiting
- Schizophrenia
- +2 more
- Transcranial direct current stimulation
- Executive function training
-
Whitby, Ontario, CanadaOntario Shores Centre for Mental Health Sciences (Ontario Shores
Oct 31, 2022
Cardiorenal Syndrome (CRS) Trial in Rochester (Candesartan, Placebo)
Completed
- Cardiorenal Syndrome (CRS)
- Candesartan
- Placebo
-
Rochester, MinnesotaMayo Clinic
Oct 20, 2021
Bladder Cancer, Bladder Tumors, Bladder Tumors Trial in Beijing (Pembrolizumab)
Recruiting
- Bladder Cancer
- +4 more
-
Beijing, Beijing, ChinaPeking University First Hospital
Dec 18, 2021